Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Press release

Alligator Bioscience: BioStock: Alligator's CEO: "I'm confident that we will strike a deal"

Alligator Bioscience

Alligator Bioscience is currently conducting a rights issue aimed at advancing mitazalimab towards phase III and securing a partnership. CEO Søren Bregenholt joins BioStock's studio to discuss the recently announced cost-saving program, mitazalimab's clinical data, and the company's efforts to achieve a partnership for the candidate.
A number of companies are doing due diligence, says Søren Bregenholt.

Watch the interview with Alligator Bioscience at biostock.se:

https://www.biostock.se/en/2025/01/alligators-ceo-im-confident-that-we-will-strike-a-deal

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.